Literature DB >> 15373915

IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients.

S de la Barrera1, M Aleman, R Musella, P Schierloh, V Pasquinelli, V Garcia, E Abbate, M del C Sasiain.   

Abstract

Activation of T cells requires both TCR-specific ligation and costimulation through accessory molecules during T cell priming. IFNgamma is a key cytokine responsible for macrophage activation during Mycobacterium tuberculosis (Mtb) infection while IL-10 is associated with suppression of cell mediated immunity in intracellular infection. In this paper we evaluated the role of IFNgamma and IL-10 on the function of cytotoxic T cells (CTL) and on the modulation of costimulatory molecules in healthy controls and patients with active tuberculosis (TB). gamma-irradiated-Mtb (i-Mtb) induced IL-10 production from CD14(+) cells from TB patients. Moreover, CD3(+) T cells of patients with advanced disease also produced IL-10 after i-Mtb stimulation. In healthy donors, IL-10 decreased the lytic activity of CD4(+) and CD8(+) T cells whereas it increased gammadelta-mediated cytotoxicity. Furthermore, we found that the presence of IL-10 induced a loss of the alternative processing pathways of antigen presentation along with a down-regulation of the expression of costimulatory molecule expression on monocytes and macrophages from healthy individuals. Conversely, neutralization of endogenous IL-10 or addition of IFNgamma to either effector or target cells from TB patients induced a strong lytic activity mediated by CD8(+) CTL together with an up-regulation of CD54 and CD86 expression on target cells. Moreover, we observed that macrophages from TB patients could use alternative pathways for i-Mtb presentation. Taken together, our results demonstrate that the presence of IL-10 during Mtb infection might contribute to mycobacteria persistence inside host macrophages through a mechanism that involved inhibition of MHC-restricted cytotoxicity against infected macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373915      PMCID: PMC1809183          DOI: 10.1111/j.1365-2249.2004.02577.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

1.  Route of monocyte differentiation determines their cytokine production profile: CD40 ligation induces interleukin 10 expression.

Authors:  A D Foey; M Feldmann; F M Brennan
Journal:  Cytokine       Date:  2000-10       Impact factor: 3.861

2.  Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.

Authors:  E H Noss; R K Pai; T J Sellati; J D Radolf; J Belisle; D T Golenbock; W H Boom; C V Harding
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells.

Authors:  T C Shaw; L H Thomas; J S Friedland
Journal:  Cytokine       Date:  2000-05       Impact factor: 3.861

5.  Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection.

Authors:  I M Orme; A D Roberts; J P Griffin; J S Abrams
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

6.  CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection.

Authors:  N V Serbina; V Lazarevic; J L Flynn
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

7.  Augmentation of signal transducer and activation of transcription (STAT)6 and STAT3 expression in stimulated B and T cells.

Authors:  Y Arinobu; R Sugimoto; M Akaiwa; K Arima; T Otsuka; N Hamasaki; K Izuhara
Journal:  Biochem Biophys Res Commun       Date:  2000-10-22       Impact factor: 3.575

8.  Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis.

Authors:  S S De La Barrera; M Finiasz; A Frias; M Alemán; P Barrionuevo; S Fink; M C Franco; E Abbate; M del C Sasiain
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

9.  Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 gamma delta T lymphocytes.

Authors:  Lorenzo Dagna; Andrea Iellem; Priscilla Biswas; Davide Resta; Francesca Tantardini; Claudio Fortis; Maria Grazia Sabbadini; Daniele D'Ambrosio; Angelo A Manfredi; Marina Ferrarini
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

10.  Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients.

Authors:  Rany Condos; Bindu Raju; Antony Canova; Ben-Yang Zhao; Michael Weiden; William N Rom; Richard Pine
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more
  29 in total

1.  A network map of Interleukin-10 signaling pathway.

Authors:  Renu Verma; Lavanya Balakrishnan; Kusum Sharma; Aafaque Ahmad Khan; Jayshree Advani; Harsha Gowda; Srikanth Prasad Tripathy; Mrutyunjay Suar; Akhilesh Pandey; Sheetal Gandotra; T S Keshava Prasad; Subramanian Shankar
Journal:  J Cell Commun Signal       Date:  2015-08-08       Impact factor: 5.782

2.  Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.

Authors:  F Abebe; T Mustafa; A H Nerland; G A Bjune
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

Review 3.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

4.  Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells.

Authors:  M Jeyanathan; S McCormick; R Lai; S Afkhami; C R Shaler; C N Horvath; D Damjanovic; A Zganiacz; N Barra; A Ashkar; M Jordana; N Aoki; Z Xing
Journal:  Mucosal Immunol       Date:  2013-10-30       Impact factor: 7.313

5.  Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis.

Authors:  Elisabetta Volpe; Giulia Cappelli; Manuela Grassi; Angelo Martino; Annalucia Serafino; Vittorio Colizzi; Nunzia Sanarico; Francesca Mariani
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

Review 6.  Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.

Authors:  Joshua C Cyktor; Joanne Turner
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

7.  Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation.

Authors:  Joshua T Mattila; Collin R Diedrich; Philana Ling Lin; Jiayao Phuah; JoAnne L Flynn
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

8.  CD3 expression distinguishes two gammadeltaT cell receptor subsets with different phenotype and effector function in tuberculous pleurisy.

Authors:  N Yokobori; P Schierloh; L Geffner; L Balboa; M Romero; R Musella; J Castagnino; G De Stéfano; M Alemán; S de la Barrera; E Abbate; M C Sasiain
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

9.  Characteristics of γδ T cells in Schistosoma japonicum-infected mouse mesenteric lymph nodes.

Authors:  Xiuxue Yu; Xueping Luo; Hongyan Xie; Dianhui Chen; Lu Li; Fan Wu; Changyou Wu; Anping Peng; Jun Huang
Journal:  Parasitol Res       Date:  2014-07-05       Impact factor: 2.289

10.  Nickel-induced IL-10 down-regulates Th1- but not Th2-type cytokine responses to the contact allergen nickel.

Authors:  J T Minang; I Areström; B Zuber; G Jönsson; M Troye-Blomberg; N Ahlborg
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.